Jeroen van Bergen

Jeroen van Bergen

Company: Immunetune

Job title: Chief Scientific Officer


Improving Neoantigen DNA Vaccines for Optimal Anti-Tumor T Cell Immunity 12:00 pm

• Discussing the importance of MHC class II restricted neoantigens • PyroVant: a novel pyroptotic adjuvant • AmpliVax: a method to produce synthetic DNA vaccines • Optimisation of intradermal vaccine deliveryRead more

day: Track B - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.